质谱鉴定PC12细胞蛋白酶体抑制剂PSI-诱导性包含体中的LBs蛋白质

路易(小)体(Lewy body, LB）构成特征的蛋白质组份（protein content）在体外形成的路易(小)体样包含体（Lewy body-like inclusion）或聚集体（aggresome）中能够获得鉴定．通过蛋白质组学方法鉴定LB蛋白质组分是一种新的途径.10 µmol/L人工合成蛋白酶体抑制剂PSI（proteasomal inhibitor）作用PC12细胞48 h使其产生PSI诱导性包含体（PSI-induced inclusions）. 为了在体外指明可能的LB蛋白质组分,通过生物化学分级分离、双向电泳（two-dimensional electrophoresis,2-D）和肽质量指纹鉴定（identification via peptide mass fingerprints,PMF）的蛋白质组学方法,鉴定了2个涉及突触递质合成的蛋白质、6个26 S蛋白酶体亚基、2个细胞骨架蛋白、2个线粒体蛋白、1个抗氧化蛋白和7个分子伴侣蛋白和（或）分子伴侣样蛋白等20个LB蛋白质组分.结果提示,当PC12细胞发生蛋白酶体抑制时,这20个LB蛋白质组分可能被富集到PSI诱导性包含体中．     

翻译起始因子5A2与肿瘤的研究进展

真核翻译起始因子5A2(eukaryotic translation initiation factor 5A2,e IF5A2)是一种在真核细胞蛋白质翻译起始和延伸过程中发挥作用的蛋白,它是e IF5A的其中一个亚型,在多种肿瘤细胞中的异常高表达往往与该肿瘤的发生和发展相关。e IF5A2所特有的羟腐赖氨酸,可以成为肿瘤治疗的潜在靶点,为临床带来新的思路。     

RNA结合模体蛋白3对细胞总蛋白质合成的影响及其靶基因的鉴定

RNA结合模体蛋白3 (RNA binding motif protein 3, RBM3) 受低温应激产生,参与介导亚低温的神经保护功能,但其作用机制及其下游靶分子尚不清楚。本研究构建了人RBM3基因的重组表达质粒,运用一种新型的、非放射性方法即翻译表面感应 (surface sensing of translation, SUnSET) 来检测RBM3过表达对细胞总蛋白质合成(global protein synthesis, GPS)的影响。结果显示,RBM3过表达使细胞总蛋白质的合成水平上调23.7% (P < 0.001),这与RBM3过表达引发的真核翻译延伸因子2 (eukaryotic translation elongation factor 2, eEF2)及真核翻译起始因子2α (eukaryotic initiation factor 2α, eIF2α) 的活性增高相一致。对RBM3可能的下游靶基因内质网蛋白3 (reticulon 3,RTN3),以及Yes相关蛋白1 (Yes-associated protein 1,YAP1) 的表达进行分析。结果显示,RBM3使RTN3及YAP1在蛋白质水平的表达分别提高了51.7% (P < 0.01) 与43.3% (P < 0.01)。与蛋白质水平变化相比,RBM3使YAP1在mRNA水平上调了2.0倍 (P < 0.001),但对RTN3的mRNA表达未见显著影响。以上研究表明,SUnSET是一种稳定、可靠的细胞GPS的检测手段;RBM3可显著促进细胞GPS,且对其下游基因RTN3和YAP1存在靶向关系。本研究的结果为深入探讨RBM3的神经保护作用机制提供了理论基础。     

癌症治疗的新靶点——eEF2K

真核生物延伸因子2激酶(eukaryotic elongation factor 2 kinase,eEF2K)由人类基因组eEF2K基因编码,归属于"α-激酶"非典型蛋白激酶小家族。eEF2K的活性要依赖于钙离子和钙调蛋白。研究显示,eEF2K在一定的代谢压力下能磷酸化并抑制真核生物延伸因子2(eukaryotic elongation factor 2,eEF2),进而抑制蛋白质合成过程中多肽链的延伸,使细胞中能量和氨基酸的消耗减少,帮助细胞适应营养或能量缺乏的不利条件。越来越多的证据显示,eEF2K可成为治疗癌症等疾病药物的新靶点。本文结合近年来报道的eEF2K小分子抑制剂探讨其在癌症等疾病治疗中的潜在价值。     

RNA结合模体蛋白3对细胞总蛋白质合成的影响及其靶基因的鉴定

RNA结合模体蛋白3 (RNA binding motif protein 3,RBM3)受低温应激产生,参与介导亚低温的神经保护功能,但其作用机制及其下游靶分子尚不清楚。本研究构建了人RBM3基因的重组表达质粒,运用一种新型的、非放射性方法即翻译表面感应(surface sensing of translation,SUnSET)来检测RBM3过表达对细胞总蛋白质合成(global protein synthesis,GPS)的影响。结果显示,RBM3过表达使细胞总蛋白质的合成水平上调23. 7%(P 0. 001),这与RBM3过表达引发的真核翻译延伸因子2 (eukaryotic translation elongation factor 2,e EF2)及真核翻译起始因子2α(eukaryotic initiation factor 2α,eIF2α)的活性增高相一致。对RBM3可能的下游靶基因内质网蛋白3(reticulon 3,RTN3),以及Yes相关蛋白1 (Yes-associated protein 1,YAP1)的表达进行分析。结果显示,RBM3使RTN3及YAP1在蛋白质水平的表达分别提高了51. 7%(P 0. 01)与43. 3%(P 0. 01)。与蛋白质水平变化相比,RBM3使YAP1在mRNA水平上调了2. 0倍(P 0. 001),但对RTN3的mRNA表达未见显著影响。以上研究表明,SUnSET是一种稳定、可靠的细胞GPS的检测手段; RBM3可显著促进细胞GPS,且对其下游基因RTN3和YAP1存在靶向关系。本研究的结果为深入探讨RBM3的神经保护作用机制提供了理论基础。     

真核翻译起始因子5A在蛋白质合成中的功能及机制

在蛋白质合成过程中,除核糖体、氨酰 tRNA和mRNA外,还有多种翻译因子参与其中。真核翻译起始因子5A（eukaryotic translation initiation factor 5A, eIF5A）是维持细胞活性必不可少的翻译因子,在进化上高度保守。eIF5A是真核细胞中唯一含有羟腐胺赖氨酸（hypusine）的蛋白质,该翻译后修饰对eIF5A的活性至关重要。1978年,人们首次鉴定出eIF5A,认为它在翻译起始阶段促进第1个肽键的形成。直到2013年才证实它主要在翻译延伸阶段调控含多聚脯氨酸基序蛋白质的翻译。在经过四十多年研究后,人们对eIF5A的功能有了新的认识。近期基于核糖体图谱数据的分析表明,eIF5A能够缓解翻译延伸过程中核糖体在多种基序处的停滞,并不局限于多聚脯氨酸基序,并且它还能够通过促进肽链的释放增强翻译终止。此外,eIF5A还可以通过调控某些蛋白质的翻译,间接影响细胞内的各种生命活动。本文综述了eIF5A的多种翻译后修饰、在蛋白质合成和细胞自噬过程中的调控作用以及与人类疾病的关系,并与细菌及古细菌中的同源蛋白质进行了比较,探讨了该因子在进化中的保守性,以期为相关领域的研究提供一定的理论基础。     

转eIF -5A及其修饰酶DHS基因选育作物新品种的研究进展

概述eIF -5A和DHS的研究与应用的进展.脱羧腐胺赖氨酸合酶(deoxyhypusine synthase,DHS)广泛分布在微生物、植物、动物的细胞中,同时参与真核细胞翻译起始因子eIF - 5A( eukaryotic initiation factor - 5A)的蛋白质合成及其延伸与折叠和翻译后修饰功能.可见eIF - 5A具有多种生物学功能,主要参与蛋白质翻译、合成蛋白质的延伸和折叠、细胞增殖、细胞周期的转化、mRNA的运输、降解、细胞衰老与凋亡等.而且eIF - 5A是DHS的唯一底物,DHS的表达被抑制的植物表现为速生、抗逆性增强、种子的产量和植株增高,开花期与果实储存期延长的特征.转调控DHS和eIF - 5A基因可能是一种农作物遗传育种的新途径.     

eEF2K与肿瘤

真核延伸因子激酶-2(eukaryotic elongation factor 2 kinase,e EF2K)属于特殊的蛋白激酶——α-激酶小家族,并且是该家族中唯一的Ca~(2+)/Ca M依赖性蛋白激酶。e EF2K催化真核延伸因子-2(eukaryotic elongation factor 2,e EF2)的Thr56位点发生磷酸化并导致其失活,从而抑制肽链延伸过程。除了受Ca~(2+)/Ca M调控,e EF2K还受到营养、能量相关信号分子如AMPK、m TORC1等的调控。近年来研究表明,e EF2K在多种肿瘤组织及细胞中高表达,并参与肿瘤生长、细胞周期、自噬、凋亡、血管新生、侵袭转移等过程的调控。因此e EF2K可能是潜在的肿瘤治疗靶点。本文就e EF2K的结构、调控,以及与肿瘤的恶性进程、治疗及预后等关系进行综述。     

真核翻译起始因子与肿瘤

真核翻译起始因子(eukaryotic translation initiation factors,eIFs)是一类在蛋白质翻译起始的过程中发挥各自不同作用的蛋白质。近年来的研究发现,eIFs除了在蛋白质翻译起始中起作用外,还具有其他的作用,而且多种eIFs均与肿瘤的发生和进展相关。现就eIFs、eIFs与肿瘤的相关性及其在肿瘤治疗方面的应用等研究进展作一综述。     

白质消融性白质脑病致病基因EIF2B的突变功能研究

白质消融性白质脑病(leukoencephalopathy with vanishing white matter,VWM)是儿童最常见的遗传性白质脑病之一,是目前人类遗传性疾病中首个被确定由于mRNA翻译启动异常所致疾病,是由编码真核细胞翻译启动因子2B(eukaryotic translation initiation factor 2B,eIF2B)的五个亚单位(eIF2Bα、β、γ、δ、ε)的基因(EIF2B1-5)任一突变所致。eIF2B是一种鸟嘌呤核苷酸交换因子,调控全部mRNA的翻译起始过程。eIF2B突变功能研究尚处于起步阶段。EIF2B突变可能通过不同的途径影响eIF2B的功能。例如,通过影响eIF2B复合体的形成或其与底物的结合从而破坏eIF2B的鸟苷酸转移因子(GEF)活性或引起细胞应激反应异常。EIF2B突变是否影响胶质前体细胞的分化是VWM发病机制的另一个关键问题。     

Effects of peroxisome proliferator-activated receptor alpha (PPARalpha) agonists on leucine-induced phosphorylation of translational targets in C2C12 cells

Effect of peroxisome proliferator-activated receptor alpha (PPARalpha) agonists, WY-14,643 (WY) and/or clofibrate, on the leucine-induced phosphorylation of translational targets in C2C12 myoblasts was studied. C2C12 cells were treated with WY or clofibrate for 24 h prior to stimulation with leucine. Western blot analyses revealed that the leucine-induced phosphorylation of p70 S6 kinase (p70S6K), a key regulator of translation initiation, was significantly higher in WY-treated cells than in control and clofibrate-treated cells. Phosphorylation of extracellular-regulated kinase (ERK1/2) was higher in WY-treated cells. WY treatment also increased the leucine-induced phosphorylation of ribosomal protein S6 and eukaryotic initiation factor 4B. In contrast, eukaryotic elongation factor 2, a marker for peptide chain elongation process, was significantly activated (dephosphorylated) only in leucine-stimulated control cells. Pre-treatment of the cells with PD98059 (ERK1/2 kinase inhibitor) prevented the phosphorylation of ERK1/2 and decreased the leucine-induced phosphorylation of p70S6K. It is concluded that WY increased the leucine-induced phosphorylation of target proteins involving in translation initiation via ERK/p70S6K pathway, but impaired the signaling for elongation process, suggesting that p70S6K phosphorylation may be essential, but not sufficient for the activation of entire targets for protein translation in WY-treated cells.     

Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain

The pathogenesis of formation of neurofibrillary tangles (NFTs) in Alzheimer's disease (AD) brains is unknown. One of the possibilities might be that translation of tau mRNA is aberrantly regulated in AD brains. In the current study, levels of various translation control elements including total and phosphorylated (p) forms of mammalian target of rapamycin (mTOR), eukaryotic initiation factor 4E binding protein 1 (4E-BP1), eukaryotic elongation factor 2 (eEF2), and eEF2 kinase were investigated in relationship with tau in homogenates of the medial temporal cortex from 20 AD and 10 control brains. We found that levels of p-mTOR (Ser2481), and p-4E-BP1 (Thr70 and Ser65) dramatically increase in AD, and are positively significantly correlated with total tau and p-tau. Levels of p-eEF2K were significantly increased, and total eEF2 significantly decreased in AD, when compared to controls. The changes of p-mTOR (2481), p-4E-BP1, and p-eEF2 were immunohistochemically confirmed to be in neurons of AD brains. This suggested that there are obvious abnormalities of elements related with translation control in AD brain and their aberrant changes may up-regulate the translation of tau mRNA, contributing to hyperphosphorylated tau accumulation in NFT-bearing neurons.     

The elongation, termination, and recycling phases of translation in eukaryotes

This work summarizes our current understanding of the elongation and termination/recycling phases of eukaryotic protein synthesis. We focus here on recent advances in the field. In addition to an overview of translation elongation, we discuss unique aspects of eukaryotic translation elongation including eEF1 recycling, eEF2 modification, and eEF3 and eIF5A function. Likewise, we highlight the function of the eukaryotic release factors eRF1 and eRF3 in translation termination, and the functions of ABCE1/Rli1, the Dom34:Hbs1 complex, and Ligatin (eIF2D) in ribosome recycling. Finally, we present some of the key questions in translation elongation, termination, and recycling that remain to be answered.     

Heat shock protein 70 promotes coxsackievirus B3 translation initiation and elongation via Akt‐mTORC1 pathway depending on activation of p70S6K and Cdc2

We previously demonstrated that coxsackievirus B3 (CVB3) infection upregulated heat shock protein 70 (Hsp70) and promoted CVB3 multiplication. Here, we report the underlying mechanism by which Hsp70 enhances viral RNA translation. By using an Hsp70‐overexpressing cell line infected with CVB3, we found that Hsp70 enhanced CVB3 VP1 translation at two stages. First, Hsp70 induced upregulation of VP1 translation at the initiation stage via upregulation of internal ribosome entry site trans‐acting factor lupus autoantigen protein and activation of eIF4E binding protein 1, a cap‐dependent translation suppressor. Second, we found that Hsp70 increased CVB3 VP1 translation by enhancing translation elongation. This was mediated by the Akt‐mammalian target of rapamycin complex 1 signal cascade, which led to the activation of eukaryotic elongation factor 2 via p70S6K‐ and cell division cycle protein 2 homolog (Cdc2)‐mediated phosphorylation and inactivation of eukaryotic elongation factor 2 kinase. We also determined the position of Cdc2 in this signal pathway, indicating that Cdc2 is regulated by mammalian target of rapamycin complex 1. This signal transduction pathway was validated using a number of specific pharmacological inhibitors, short interfering RNAs (siRNAs) and a dominant negative Akt plasmid. Because Hsp70 is a central component of the cellular network of molecular chaperones enhancing viral replication, these data may provide new strategies to limit this viral infection.     

A critical role of eEF-2K in mediating autophagy in response to multiple cellular stresses

The phosphorylation of the subunit α of eukaryotic translation initiation factor 2 (eIF2α), a critical regulatory event in controlling protein translation, has recently been found to mediate the induction of autophagy. However, the mediators of autophagy downstream of eIF2α remain unknown. Here, we provide evidence that eIF2α phosphorylation is required for phosphorylation of eukaryotic elongation factor 2 (eEF-2) during nutrient starvation. In addition, we show that eukaryotic elongation factor 2 kinase (eEF-2K) is also required for autophagy signaling during ER stress, suggesting that phosphorylation

of eEF-2 may serve as an integrator of various cell stresses for autophagy signaling. On the other hand, although the activation of eEF-2K in response to starvation requires the phosphorylation of eIF2α, additional pathways relying partly on Ca²⁺ flux may control eEF-2K activity during ER stress, as eIF2α phosphorylation is dispensable for both eEF-2 phosphorylation and autophagy in this context.     

Caerulein-induced acute pancreatitis inhibits protein synthesis through effects on eIF2B and eIF4F

Acute pancreatitis (AP) has been shown in some studies to inhibit total protein synthesis in the pancreas, whereas in other studies, protein synthesis was not affected. Previous in vitro work has shown that high concentrations of cholecystokinin both inhibit protein synthesis and inhibit the activity of the guanine nucleotide exchange factor eukaryotic initiation factor (eIF)2B by increasing the phosphorylation of eIF2alpha. We therefore evaluated in C57BL/6 mice the effects of caerulein-induced AP on pancreatic protein synthesis, eIF2B activity and other protein translation regulatory mechanisms. Repetitive hourly injections of caerulein were administered at 50 microg/kg ip. Pancreatic protein synthesis was reduced 10 min after the initial caerulein administration and was further inhibited after three and five hourly injections. Caerulein inhibited the two major regulatory points of translation initiation: the activity of the guanine nucleotide exchange factor eIF2B (with an increase of eIF2alpha phosphorylation) and the formation of the eIF4F complex due, in part, to degradation of eIF4G. This inhibition was not accounted for by changes in the upstream stimulatory pathway, because caerulein activated Akt as well as phosphorylating the downstream effectors of mTOR, 4E-BP1, and ribosomal protein S6. Caerulein also decreased the phosphorylation of the eukaryotic elongation factor 2, implying that this translation factor was not inhibited in AP. Thus the inhibition of pancreatic protein synthesis in this model of AP most likely results from the inhibition of translation initiation as a result of increased eIF2alpha phosphorylation, reduction of eIF2B activity, and the inhibition of eIF4F complex formation.     

A novel role of the mammalian GSPT/eRF3 associating with poly(A)-binding protein in Cap/Poly(A)-dependent translation

The mammalian GSPT, which consists of amino-terminal (N) and carboxyl-terminal (C) domains, functions as the eukaryotic releasing factor 3 (eRF3) by interacting with eRF1 in translation termination. This function requires only the C-domain that is homologous to the elongation factor (EF) 1alpha, while the N-domain interacts with polyadenylate-binding protein (PABP), which binds the poly(A) tail of mRNA and associates with the eukaryotic initiation factor (eIF) 4G. Here we describe a novel role of GSPT in translation. We first determined an amino acid sequence required for the PABP interaction in the N-domain. Inhibition of this interaction significantly attenuated translation of capped/poly(A)-tailed mRNA not only in an in vitro translation system but also in living cells. There was a PABP-dependent linkage between the termination factor complex eRF1-GSPT and the initiation factor eIF4G associating with 5' cap through eIF4E. Although the inhibition of the GSPT-PABP interaction did not affect the de novo formation of an 80 S ribosomal initiation complex, it appears to suppress the subsequent recycle of ribosome. These results indicate that GSPT/eRF3 plays an important role in translation cycle through the interaction with PABP, in addition to mediating the termination with eRF1.